Eric Huefner

Title: Eric Huefner: Innovator in Fucosyltransferase Research

Introduction

Eric Huefner is a notable inventor based in Hennef, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of fucosyltransferases. With a total of 3 patents to his name, his work has implications for various applications in biochemistry and medicine.

Latest Patents

One of Eric Huefner's latest patents is titled "Fucosyltransferases and their applications." This invention relates to nucleic acid and amino acid sequences from serogroup O126, which code for a novel alpha-1,2-fucosyltransferase. The patent also outlines methods for using this enzyme to generate fucosylated products, such as oligosaccharides, (glyco)proteins, and (glyco)lipids, with a particular focus on oligosaccharides found in human milk, like 2'-fucosyllactose. Another significant patent is "Method for the production of fucosyllactose in bacterial cells." This invention describes a cell that can be stably cultured in a medium, adjusted for the production of oligosaccharides. The cell is transformed to include nucleic acid sequences coding for enzymes involved in oligosaccharide synthesis and proteins of the sugar efflux transporter family.

Career Highlights

Eric Huefner is currently employed at Jennewein Biotechnologie GmbH, where he continues to advance his research in fucosyltransferases. His work is pivotal in developing biotechnological solutions that can enhance the production of important oligosaccharides.

Collaborations

Throughout his career, Eric has collaborated with notable colleagues, including Stefan Jennewein and Julia Parkot. These collaborations have further enriched his research and contributed to the advancements in the field.

Conclusion

Eric Huefner's innovative work in fucosyltransferase research exemplifies the impact of biotechnology on health and nutrition. His patents and ongoing research continue to pave the way for new applications in the industry.